Difficult Decisions in Thoracic Surgery - part 8 pptx
Difficult Decisions in Thoracic Surgery - part 8 pptx
... Video-Assisted Thoracic Surgery
In 1996, Mouroux and colleagues
18
proposed plica-
tion through a video-assisted thoracic surgery
(VATS) approach. Two 5-mm thoracic ports and a
4-cm minithoracotomy ...
achieved within 3 days in both patients undergo-
ing surgery for this indication.
44.3.1.2. Long-term Outcome
In some surgical series of pediatric patients,
information...
Difficult Decisions in Thoracic Surgery - part 1 ppsx
... Number: 2006926462
ISBN-10: 1 -8 462 8- 3 8 4-1 e-ISBN 1 -8 462 8- 4 7 0-0 Printed on acid-free paper
ISBN-13: 97 8- 1 -8 4 62 8- 3 8 4-0
© Springer-Verlag London Limited 2007
Apart from any fair dealing for the purposes ... Data
Diffi cult decisions in thoracic surgery
1. Chest — Surgery — Decision making 2. Chest — surgery
I. Ferguson, Mark K.
617.5′4
ISBN-13: 9...
Difficult Decisions in Thoracic Surgery - part 2 ppt
... for mediastinal staging
in patients with non-small cell lung cancer. Ann
Int Med 2003;139 :87 9 89 2.
7. The Canadian Lung Oncology Group. Investiga-
tion for mediastinal disease in patients ... computed tomography for mediastinal staging
in patients with non-small-cell lung cancer: a
meta-analysis. Ann Intern Med 2003;139 :87 9–
89 2.
25. Viney RC, Boyer MJ, King MT, et al. Random...
Difficult Decisions in Thoracic Surgery - part 3 potx
... operation in satisfying surgical oncologic
principles remains a hurdle in many surgeons’
minds. The main considerations, therefore, in
assessing whether to perform a minimally inva-
sive lobectomy ... effusion)
Stamatis
6
58 32 Medlastinal (Cisplatin + VP-16) × 3 61% 59% 48% 47% 5 .8% 26% (5 year) 28% (5 year)
N3 + (Cisplatin + VP-16) C.R.: 43%
T4 × 1 + RT 45 Gy) (5-sp)
SWOG
10...
Difficult Decisions in Thoracic Surgery - part 4 potx
... Cardiovasc Surg
1 989 ; 98: 884 89 0.
10. Burt ME, Wronski M, Arbit E, Galicich JH. Resec-
tion of brain metastases from non-small-cell
lung carcinoma. Results of therapy. Memorial
Sloan-Kettering Cancer ... 2001;71: 981 89 5.
21. Martin J, Ginsberg RJ, Venkatraman ES, et al.
Long-term results of combined-modality therapy
in resectable non-small-cell lung cancer. J Clin
Oncol 2002;20...
Difficult Decisions in Thoracic Surgery - part 5 pot
... main-
taining gut motility.
11
There are instances,
however, in which oral intake may be precluded,
including depressed mentation, incompetence of
swallowing with aspiration, upper gastrointesti-
nal ... 1992;53: 289 –294.
33. Fok M, Ah-Chong AK, Cheng SWK, et al. Com-
parison of a single-layer, continuous hand-
sewn method and circular stapling in 580
oesophageal anastomoses. Br J...
Difficult Decisions in Thoracic Surgery - part 6 pdf
... randomized to surgery alone or surgery
and postoperative chemotherapy with cisplatin and
vindesine. The 5-year overall survival was 45% in
patients with surgery alone and 48% in patients with
surgery ... sphinc-
ter (LES).
• Botox: Flexible endoscopic injection of purifi ed
Botulinum toxin (a potent neurotoxin) into the
musculature of the LES. Typically 100 units of
the toxin...
Difficult Decisions in Thoracic Surgery - part 7 pdf
... 19 98 100 Mini-invasive 0
Patti
50
19 98 201 Mini-invasive 0
Meyer
48
19 98 224 Mini-invasive 0
Peters
52
19 98 100 Mini-invasive 0
McKernan
15
19 98 9 68 Mini-invasive 1.9%
Johnson
10
19 98 220 ... 0
Anvari
27
19 98 381 Mini-invasive 0
Dallemagne
35
19 98 622 Mini-invasive 0
Eshraghi
37
19 98 157 Mini-invasive 0
Kiviluoto
42
19 98 200 Mini-invasive 0
Landreneau
44
19 98...
Difficult Decisions in Thoracic Surgery - part 9 potx
... Thorax 1 982 ;37:46– 48.
18. Sharma TN, Agrihotri SP, Jain NK, et al. Intercos-
tal tube thoracostomy in pneumothorax: factors
in uencing re-expansion of lung. Ind J Chest Dis
Allied Sci 1 988 ;30:32–35.
... selective binding may
offer two distinct benefi ts. First, by being active
only on bound plasminogen, it activates plasmin-
ogen that can cleave fi brin strands, causing locu-
lati...
Difficult Decisions in Thoracic Surgery - part 10 ppt
... 488
extrapericardial, 488 , 489 , 490,
491
intrapericardial, 488 , 489 , 490,
491
life-threatening complications
of, 488 , 489 –490, 491
prevalence of, 488 – 489
treatment guidelines for, 490–491
pH, twenty-four hour ... 447
Penetrating injuries,
diaphragmatic, 379, 382
Penicillin, 5
Percutaneous Coronary
Interventions, 41–42
Pericardial effusions
malignant, 482 – 487
catheter-based...